What is it about?
The prognostic role of Neutrophil-to-Lymphocyte ratio in Non-small cell lung cancer treated with Epidermal growth factor receptor Tyrosine kinase inhibitor.
Featured Image
Why is it important?
NLR and MLR are the none-invassive markers. Compared with other serum markers as Cyfra 21–1, CA12-5, NSE or imaging diagnostic tools as PET-CT, CT-scanner or MRI, the use of inflammatory markers as NLR and MLR in treatment monitoring will ensure the safety of patients while maintaining low cost and being easy to implement.
Perspectives
We hope these markers will be applied in the clinical practice soon.
Thang Phan
Lab-D Unit, Clinical Cancer Center, Cho Ray hospital, HCMC, 700000, Vietnam
Read the Original
This page is a summary of: The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small-cell lung cancer patients treated with EGFR TKI, International Journal of General Medicine, November 2018, Dove Medical Press,
DOI: 10.2147/ijgm.s174605.
You can read the full text:
Contributors
The following have contributed to this page
